Insight Molecular Diagnostics Inc. (IMDX)
(Delayed Data from NSDQ)
$3.08 USD
-0.19 (-5.81%)
Updated Sep 23, 2025 02:27 PM ET
3-Hold of 5 3
F Value B Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IMDX 3.08 -0.19(-5.81%)
Will IMDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMDX
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
IMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IMDX
NR7 appears for IMDX after 4.11% move
Pocket Pivot appears for IMDX after 1.19% move
Is IMDX primed for upward momentum? Upper Bollinger Band Walk shows up after gaining 1.81%
Insight Molecular Diagnostics Approves Executive Salary Increases
Is IMDX preparing to trend higher? New Uptrend shows up after slipping 3.78%